In a recent interview, Health and Human Services Secretary Robert F. Kennedy Jr. revealed that he cautioned President Trump regarding a study suggesting a potential link between Tylenol use during pregnancy and an increased risk of autism.
Kennedy recounted that Trump initially seemed ready to make a significant social media announcement but he advised against it. “You can’t do that,” he said, emphasizing the complexities involved and the risk of alarming the public about Tylenol. He noted that major pharmaceutical companies would likely push back strongly against such statements.
However, Trump reportedly brushed off Kennedy’s warnings, telling his Cabinet, “I’m not going to say anything about it.”
On September 22, President Trump alongside Kennedy and other federal health officials conveyed concerns about the widely used pain reliever. Trump stated, “Don’t take Tylenol. Don’t take it. Fight like hell not to take it.” This sparked surprise among many medical experts, who pointed out that Tylenol has been considered one of the safer choices for pain relief during pregnancy.
Interestingly, Kennedy acknowledged that high fevers in pregnant women can harm the developing fetus. His interest in the Tylenol issue was piqued by a review conducted by Andrea Vaccarelli, the dean of Harvard’s TH Chan School of Public Health, which examined existing research on the connection between acetaminophen—the main ingredient in Tylenol—and higher autism rates. But, it’s worth noting, this study didn’t definitively conclude that there was a link.
According to reports, Kennedy scrutinized over 70 studies on the subject and consulted multiple experts before discussing his concerns with Trump.
In 2017, Tylenol had posted on social media that they did not recommend using their products during pregnancy, a message that gained traction following the administration’s announcement.
Senator Bill Cassidy (R-Louisiana), who chairs the Senate Health Committee, publicly challenged the statement made by the Trump administration, asserting that new data should be released to support such claims. He expressed concern that the announcement might limit pain management options for pregnant women and emphasized the need for compassion in discussing this topic.
Interestingly, records show that Kennedy and Cassidy have had significant disagreements over vaccines, which adds a layer of complexity to their relationship.
